云南高校图书馆联盟文献共享服务平台- PSA

PSA: 作品数：2796被引量：4842H指数：21; 导出分析报告; 相关领域：医药卫生更多>>; 相关作者：符本琪吴宜灿赵雪俭孙福康潘慈康更多>>; 相关机构：苏州热工研究院有限公司复旦大学苏州大学上海核工程研究设计院更多>>; 相关期刊：更多>>; 相关基金：国家自然科学基金国家高技术研究发展计划国家重点基础研究发展计划国家科技重大专项更多>>

PSA as the driving biomarker to manage low-and intermediate-risk prostate cancer patients in clinical practice被引量：1: 《Asian Journal of Andrology》2024年第6期567-568,共2页Enrico Ricevuto Celeste Morgani Fabrizia Seri Gemma Bruera; Prostate cancer risk stratification relies on several clinical factors. Low-risk patients, characterized by T1–T2a stage, Gleason score (GS) ≤6, and prostate-specific antigen (PSA) <10 ng ml−1, exhibit an excellent ...; 关键词：patients CLINICAL cancer

Peripheral zone PSA density:a predominant variable to improve prostate cancer detection efficiency in men with PSA higher than 4 ng ml^(-1)被引量：1: 《Asian Journal of Andrology》2021年第4期415-420,共6页Cheng Wang Yue-Yang Wang Shi-Yuan Wang Ji-Xiang Ding Mao Ding Yuan Ruan Xiao-Hai Wang Yi-Feng Jing Bang-Min Han Shu-Jie Xia Chen-Yi Jiang Fu-Jun Zhao; This study was supported by the National Natural Science Foundation of China(No.81772746,No.81870516);Natural Science Foundation of Xinjiang Province(2019D01C091).; To improve the diagnostic efficiency of prostate cancer(PCa)and reduce unnecessary biopsies,we defined and analyzed the diagnostic efficiency of peripheral zone prostate-specific antigen(PSA)density(PZ-PSAD).Patients ...; 关键词：benign prostate hyperplasia detection efficiency peripheral zone prostate-specific antigen density prostate biopsy prostate-specific antigen prostatic neoplasm

PSA density in the diagnosis of prostate cancer in the Chinese population: results from the Chinese Prostate Cancer Consortium被引量：10: 《Asian Journal of Andrology》2021年第3期300-305,共6页Zi-Jian Song Jin-Ke Qian Yue Yang Han-Xiao Wu Mao-Yu Wang Si-Yuan Jiang Fu-Bo Wang Wei Zhang Rui Chen Chinese Prostate Cancer Consortium; for National Natural Science Foundation Youth Project(No.81702514 to RC).; We performed this study to investigate the diagnostic performance of prostate-specific antigen density(PSAD)in a multicenter cohort of the Chinese Prostate Cancer Consortium.Outpatients with prostate-specific antigen(...; 关键词：CHINESE early detection of cancer prostate cancer prostate-specific antigen prostate-specific antigen density

PSA screening-for whom and when?: 《Asian Journal of Andrology》2019年第1期3-5,共3页Peter Albers; Reasons for and against screening of,prostate cancer have been discussed widely over the last decade.In 2014,the European Randomized Trial for Screening of Prostate Cancer(ERSPC)has reported a relative reduction of th...; 关键词：PSA ERSPC

Evaluation of PSA-age volume score in predicting prostate cancer in Chinese population被引量：4: 《Asian Journal of Andrology》2018年第4期324-329,共6页Yi-Shuo Wu Xiao-Bo Wu Ning Zhang Guang-Liang Jiang Yang Yu Shi-Jun Tong Hao-Wen Jiang Shan-Hua Mao Rong Na Qiang Ding; This study was performed to evaluate prostate-specific antigen-age volume （PSA-AV） scores in predicting prostate cancer （PCa） in a Chinese biopsy population. A total of 2355 men who underwent initial prostate biop...; 关键词：age China prostate cancer prostate-specific antigen VOLUME

PSA time to nadir as a prognostic factor of first-line docetaxel treatment in castration-resistant prostate cancer： evidence from patients in Northwestern China被引量：1: 《Asian Journal of Andrology》2018年第2期173-177,共5页Kai-Jie Wu Xin-Qi Pei Ge Tian Da-Peng Wu Jin-Hai Fan Yu-Mei Jiang Da-Lin He; This study was partially supported by the National Natural Science Foundation of China （NSFC 81202014 to KJW, NSFC 81130041 to DLH） and the Fundamental Research Funds for the Central Universities （to KIW）.; Docetaxel-based chemotherapy remains the first-line treatment for patients with metastatic castration-resistant prostate cancer （mCRPC） in China; however, the prognostic factors associated with effects in these pati...; 关键词：castration-resistant prostate cancer CHEMOTHERAPY DOCETAXEL prostate-specific antigen SURVIVAL time to nadir

PSA density improves the rate of prostate cancer detection in Chinese men with a PSA between 2.5-10.0 ng ml-1 and 10.1-20.0 ng ml-1： a multicenter study被引量：16: 《Asian Journal of Andrology》2015年第3期503-507,共5页Yu-Rong Lin Xing-Hua Wei Matthew Uhlman Xuan-Ting Lin Si-Feng Wu Peng-Fei Diao Hai-Qing Xie Ke-Ji Xie Ping Tang; Chinese men should have a higher prostate-specific antigen （PSA）＂gray zone＂ than the traditional value of 2.5-10.0 ng ml-1 since the incidence of prostate cancer （PCa） in Chinese men is relative low. We hypothe...; 关键词：area under the receiver operating characteristic curve prostate cancer prostate-specific antigen prostate-specificantigen density

Fasting times in serum PSA assay被引量：1: 《Asian Journal of Andrology》2014年第5期786-786,共1页Xiang Xu Julia Lipianskaya Jiaoti Huang; Prostate-specific antigen （PSA） test for prostate cancer is the only serum-based cancer screening test that is widely accepted. A large number of PSA tests are done in developed countries such as the United States d...

A population study of fasting time and serum prostate-specific antigen （PSA） level被引量：1: 《Asian Journal of Andrology》2014年第5期740-744,I0009,I0010,共7页Cheryl K Lau Maggie Guo Jeannine A Viczko Christopher T Naugler; Prostate cancer is one of the most common cancers in men. Traditional screening and diagnostic methods include digital rectal examinations （DREs）, biopsies and serum prostate-specific antigen （PSA） tests, with the...; 关键词：diagnostic test FASTING prostate-specific antigen （PSA）

Current early diagnostic biomarkers of prostate cancer被引量：2: 《Asian Journal of Andrology》2014年第4期549-554,共6页Min Qu Shan-Cheng Ren Yinghao Sun; This study was supported by the National Basic Research Program of China （No. 2012CB518306）, the National Natural Science Foundation of China （No. 81101946）, the Prostate Cancer Foundation Young Investigator Award, and the Shanghai Pujiang Program （No. 12PJD008）.; Prostate cancer （PCa） has become to have the highest incidence and the second mortality rate in western countries, affecting men＇s health to a large extent. Although prostate-specific antigen （PSA） was discovered...; 关键词：early diagnostic biomarkers MALATl-derived miniRNA PCA3 prostate cancer PSA

PSA